Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16481347rdf:typepubmed:Citationlld:pubmed
pubmed-article:16481347lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C1425141lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:16481347lifeskim:mentionsumls-concept:C1517050lld:lifeskim
pubmed-article:16481347pubmed:issue3lld:pubmed
pubmed-article:16481347pubmed:dateCreated2006-2-27lld:pubmed
pubmed-article:16481347pubmed:abstractTextMembers of the T cell, Ig domain and mucin domain (Tim) family of proteins have recently been implicated in the control of T cell-mediated immune responses. Tim-1 (HUGO designation HAVCR1) polymorphisms have been linked to the regulation of atopy in mice and humans, suggestive of a role in immune regulation. Tim-1 is expressed upon activation of T cells. In concert with the increased expression of Tim-1, a binding partner for the extracellular domain of Tim-1 (eTim-1) was induced on activated T cells, and mRNA expression data was consistent with the binding partner being Tim-4. We found that co-immobilized recombinant eTim-1 was able to inhibit T cell activation mediated by CD3 + CD28 mAb. eTim-1 mediated its inhibitory effects on proliferation by arresting cell cycle at G(0)/G(1) phase through regulation of cell cycle proteins. In vivo, administration of eTim-1 proteins led to a decrease in both ear (contact hypersensitivity to oxazolone) and joint (methylated BSA antigen-induced arthritis) swelling. The inhibitory activity of eTim-1 in the T(h)1-dependent models was evidence that eTim-1 is able to modulate T cell responses. Manipulation of the Tim-1 interaction with its binding partner on T cells may therefore provide a novel target for therapeutic intervention in T cell-mediated diseases.lld:pubmed
pubmed-article:16481347pubmed:languageenglld:pubmed
pubmed-article:16481347pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16481347pubmed:citationSubsetIMlld:pubmed
pubmed-article:16481347pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16481347pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16481347pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16481347pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16481347pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16481347pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16481347pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16481347pubmed:statusMEDLINElld:pubmed
pubmed-article:16481347pubmed:monthMarlld:pubmed
pubmed-article:16481347pubmed:issn0953-8178lld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:MolJ CJClld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:GhatpandeAshw...lld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:ChapovalAndre...lld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:StarlingGary...lld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:ShimketsRicha...lld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:HackettCraigClld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:ShenoySureshSlld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:BendeleAlison...lld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:BurgessCather...lld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:SmithsonGlenn...lld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:BoldogFerencFlld:pubmed
pubmed-article:16481347pubmed:authorpubmed-author:PenaCarol ECElld:pubmed
pubmed-article:16481347pubmed:issnTypePrintlld:pubmed
pubmed-article:16481347pubmed:volume18lld:pubmed
pubmed-article:16481347pubmed:ownerNLMlld:pubmed
pubmed-article:16481347pubmed:authorsCompleteYlld:pubmed
pubmed-article:16481347pubmed:pagination473-84lld:pubmed
pubmed-article:16481347pubmed:dateRevised2007-6-20lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:meshHeadingpubmed-meshheading:16481347...lld:pubmed
pubmed-article:16481347pubmed:year2006lld:pubmed
pubmed-article:16481347pubmed:articleTitleInhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins.lld:pubmed
pubmed-article:16481347pubmed:affiliationCuraGen Corporation, Branford, CT 06405, USA. info@curagen.comlld:pubmed
pubmed-article:16481347pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:26762entrezgene:pubmedpubmed-article:16481347lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16481347lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16481347lld:pubmed